3/5/13 10:03 | 3/1/13 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | P,Alere | M.d | 41 | 16.20 | 16 | 3 | 3 | 77 | D | -39 | -9 | 23 | 29 | 11 | 9 | 5 | 3 | 1 | 4 | 10 | 10 | 34 | 58 |
3/5/13 10:03 | 3/1/13 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | P,Alere | S.d | -54 | 22.69 | 16 | -2 | -3 | 77 | D | -39 | -9 | 23 | 29 | 11 | 9 | 5 | 3 | 1 | 4 | 10 | 10 | 34 | 58 |
11/17/11 16:29 | 11/15/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | Chief Co | M.d | 267 | 15.47 | 24 | 17 | 29 | 77 | D | -39 | -11 | -37 | 12 | 27 | -1 | -1 | -1 | -5 | -11 | -9 | 3 | -25 | -28 |
11/17/11 16:29 | 11/15/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | Chief Co | S.d | -448 | 26.02 | 24 | -17 | -18 | 77 | D | -39 | -11 | -37 | 12 | 27 | -1 | -1 | -1 | -5 | -11 | -9 | 3 | -25 | -28 |
8/1/11 13:19 | 7/29/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | Chief Co | M.d | 352 | 15.47 | 27 | 23 | 42 | 77 | D | -11 | 5 | -25 | -21 | -17 | -20 | -19 | -13 | -2 | -12 | -16 | -12 | -18 | -37 |
3/1/11 21:34 | 2/25/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | Chief Co | M.d | 73 | 15.91 | 23 | 5 | 9 | 54 | D | 72 | -3 | 34 | 23 | -2 | -3 | -3 | 5 | 0 | 0 | -1 | 5 | -38 | -32 |
3/1/11 21:25 | 1/19/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | Chief Co | M.ad | 18 | 14.92 | 23 | 1 | 3 | 45 | D | 72 | -3 | 34 | 23 | -2 | -3 | -3 | 5 | 0 | 0 | -1 | 5 | -38 | -32 |
1/28/11 15:55 | 1/26/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | Chief Co | M.d | 60 | 14.92 | 26 | 4 | 12 | 38 | I | 60 | -2 | 41 | 38 | 17 | 4 | 2 | 3 | -3 | -2 | -4 | -8 | -28 | -40 |
1/21/11 14:44 | 1/19/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | Chief Co | M.d | 18 | 14.92 | 24 | 1 | 4 | 34 | D | 60 | -8 | 44 | 28 | 19 | 7 | 3 | -1 | -1 | 3 | -3 | -1 | -7 | -42 |
4/11/08 10:04 | 2/29/08 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | P,Consum | M.d | 2 | 2.44 | 0 | 1 | 2 | 34 | D | | | | | | | | | | | | | | |
12/7/07 12:06 | 12/5/07 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | P,Consum | M.d | 8 | 3.17 | 0 | 3 | 8 | 33 | M | | | | | | | | | | | | | | |
6/22/06 17:34 | 6/21/06 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | P,Consum | P | 0 | 0.00 | 0 | 25 | 427 | 31 | S | | | | | | | | | | | | | | |
5/6/04 16:57 | 3/22/04 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | | O | VP - Int | M.d | 3 | 1.24 | 0 | 3 | 147 | 4 | I | | | | | | | | | | | | | | |